Javascript must be enabled to continue!
Development of calcium oxalate crystallization index for estimating lithogenic potential in urines of patients with nephrolithiasis
View through CrossRef
Nephrolithiasis is a significant health problem in Thailand. It is known that urinary crystals are building blocks of kidney calculi, and urinary supersaturation triggers crystal formation. The most common type of lithogenic crystals is calcium oxalate (CaOx). In this study, a new test, designated CaOx crystallization index (COCI), was developed to distinguish nephrolithiasis patients from healthy individuals based on the urinary crystallization capability. The effect of urine volume, oxalate, phosphate, citrate, potassium and sodium on COCI values was investigated. COCI values were determined in 24-hr urine obtained from nephrolithiasis patients (n = 72) and age- and sex-matched healthy controls (n = 71). The diagnostic potential of the urinary COCI test was evaluated. Increases in urine oxalate and phosphate caused increase in COCI values. In contrast, increases in urine volume and citrate caused decreased COCI values. Urinary COCI values of nephrolithiasis group were significantly higher than that of healthy group. Importantly, asymptomatic kidney calculi were detected by ultrasound imaging in two healthy subjects with elevated COCI values. Based on receiver operating characteristic (ROC) analysis, an area under ROC curve of the urinary COCI test was 0.9499 (95%CI: 0.9131-0.9868), indicated that this test had excellent discriminatory power to separate nephrolithiasis from healthy subjects. At the cutoff of 165 mg oxalate equivalence/day, the COCI test provided sensitivity, specificity and accuracy of 83.33, 97.18 and 90.21%, respectively. In conclusion, the COCI test was successfully established, and its values were primarily dependent on urine volume, oxalate, phosphate and citrate. The test provided high sensitivity and specificity for clinically discriminating the nephrolithiasis patients from healthy population. We suggest that the COCI test is a cheap, simple, non-invasive and reliable method that could be implemented in hospital laboratories to identify individuals at risk of kidney stone formation as well as those with asymptomatic urinary calculi or early stage of nephrolithiasis.
Title: Development of calcium oxalate crystallization index for estimating lithogenic potential in urines of patients with nephrolithiasis
Description:
Nephrolithiasis is a significant health problem in Thailand.
It is known that urinary crystals are building blocks of kidney calculi, and urinary supersaturation triggers crystal formation.
The most common type of lithogenic crystals is calcium oxalate (CaOx).
In this study, a new test, designated CaOx crystallization index (COCI), was developed to distinguish nephrolithiasis patients from healthy individuals based on the urinary crystallization capability.
The effect of urine volume, oxalate, phosphate, citrate, potassium and sodium on COCI values was investigated.
COCI values were determined in 24-hr urine obtained from nephrolithiasis patients (n = 72) and age- and sex-matched healthy controls (n = 71).
The diagnostic potential of the urinary COCI test was evaluated.
Increases in urine oxalate and phosphate caused increase in COCI values.
In contrast, increases in urine volume and citrate caused decreased COCI values.
Urinary COCI values of nephrolithiasis group were significantly higher than that of healthy group.
Importantly, asymptomatic kidney calculi were detected by ultrasound imaging in two healthy subjects with elevated COCI values.
Based on receiver operating characteristic (ROC) analysis, an area under ROC curve of the urinary COCI test was 0.
9499 (95%CI: 0.
9131-0.
9868), indicated that this test had excellent discriminatory power to separate nephrolithiasis from healthy subjects.
At the cutoff of 165 mg oxalate equivalence/day, the COCI test provided sensitivity, specificity and accuracy of 83.
33, 97.
18 and 90.
21%, respectively.
In conclusion, the COCI test was successfully established, and its values were primarily dependent on urine volume, oxalate, phosphate and citrate.
The test provided high sensitivity and specificity for clinically discriminating the nephrolithiasis patients from healthy population.
We suggest that the COCI test is a cheap, simple, non-invasive and reliable method that could be implemented in hospital laboratories to identify individuals at risk of kidney stone formation as well as those with asymptomatic urinary calculi or early stage of nephrolithiasis.
Related Results
Synbiotic Supplementation And Oxalate Homeostasis In Rats: Focus On Microbiota Oxalate-Degrading Activity
Synbiotic Supplementation And Oxalate Homeostasis In Rats: Focus On Microbiota Oxalate-Degrading Activity
Abstract
Background The present study aimed (i) to evaluate whether ceftriaxone treatment could affect not only intestinal oxalate-degrading bacteria number but their total...
#2980 Association between body mass index and nephrolithiasis markers in the Mexican population
#2980 Association between body mass index and nephrolithiasis markers in the Mexican population
Abstract
Background and Aims
Kidney Stone Disease is a common condition with a prevalence ranging from 10% to 15% in the ...
RETRACTED: Computerized Detection of Calcium Oxalate Crystal Progression
RETRACTED: Computerized Detection of Calcium Oxalate Crystal Progression
Calcium oxalate crystals in plants can cause health issues such as kidney stones if ingested in large amounts. Calcium oxalate crystallizations affect approximately 4% of plants. S...
Pathophysiology and Treatment of Hyperoxaluria
Pathophysiology and Treatment of Hyperoxaluria
Humans cannot degrade oxalate. Thus, oxalate that is generated in the liver and/or absorbed from the intestine must be eliminated by the kidneys. Among genetic causes, primary hype...
Reduction of Oxalate Content of Foods by the Oxalate Degrading Bacterium, Eubacterium Lentum WYH‐1
Reduction of Oxalate Content of Foods by the Oxalate Degrading Bacterium, Eubacterium Lentum WYH‐1
Background: Urinary oxalate may contribute far more than urinary calcium to the pathogenesis of urinary calculi. Urinary oxalate may be reduced by restricting the intake of foods h...
Oxalate as a potent promoter of kidney stone formation
Oxalate as a potent promoter of kidney stone formation
Kidney stones are among the most prevalent urological diseases, with a high incidence and recurrence rate. Treating kidney stones has been greatly improved by the development of va...
Urinary Oxalate Excretion in Patients with Urolithiasis
Urinary Oxalate Excretion in Patients with Urolithiasis
Urinary oxalic acid excretion was determined in 21 healthy people and 70 patients with renal stones. In the group of 31 patients with calcium oxalate-containing renal stones the me...
Plasma sKL and Nrf2 Levels in Patients with Calcium Oxalate Stones
Plasma sKL and Nrf2 Levels in Patients with Calcium Oxalate Stones
Abstract
Objective To investigate the relationship between the plasma levels of sKL and Nrf2 and calcium oxalate calculi.Methods The clinical data of 135 patients with calc...

